Manulife (Manufacturers Life Insurance)
ALLO icon

Manulife (Manufacturers Life Insurance)’s Allogene Therapeutics ALLO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.6M Buy
654,180
+169,558
+35% +$340K ﹤0.01% 1589
2025
Q4 		$638K Sell
484,622
-5,355
-1% -$7.06K ﹤0.01% 2058
2025
Q3 		$608K Sell
489,977
-4,523
-0.9% -$5.39K ﹤0.01% 2118
2025
Q2 		$559K Buy
494,500
+8,634
+2% +$11.5K ﹤0.01% 2125
2025
Q1 		$709K Buy
485,866
+1,151
+0.2% +$2.17K ﹤0.01% 1967
2024
Q4 		$1.03M Sell
484,715
-1,308
-0.3% -$3.23K ﹤0.01% 1895
2024
Q3 		$1.36M Buy
486,023
+5,642
+1% +$15K ﹤0.01% 1754
2024
Q2 		$1.12M Buy
480,381
+198,231
+70% +$585K ﹤0.01% 1798
2024
Q1 		$1.26M Buy
282,150
+76,916
+37% +$321K ﹤0.01% 1722
2023
Q4 		$659K Buy
205,234
+1,369
+0.7% +$3.88K ﹤0.01% 2042
2023
Q3 		$646K Hold
203,865
– – ﹤0.01% 2002
2023
Q2 		$1.01M Buy
203,865
+2,459
+1% +$13.3K ﹤0.01% 1656
2023
Q1 		$995K Buy
201,406
+25,492
+14% +$163K ﹤0.01% 1642
2022
Q4 		$1.06M Buy
175,914
+26,916
+18% +$249K ﹤0.01% 1577
2022
Q3 		$1.55M Sell
148,998
-647
-0.4% -$8.79K ﹤0.01% 1448
2022
Q2 		$1.74M Buy
149,645
+39,402
+36% +$350K ﹤0.01% 1448
2022
Q1 		$1.02M Buy
110,243
+73,504
+200% +$766K ﹤0.01% 1739
2021
Q4 		$548 Sell
36,739
-71
-0.2% -$1.25K ﹤0.01% 2202
2021
Q3 		$946K Sell
36,810
-2,808
-7% -$66.7K ﹤0.01% 1880
2021
Q2 		$1.03M Buy
39,618
+7,751
+24% +$221K ﹤0.01% 1975
2021
Q1 		$1.13M Sell
31,867
-1,795
-5% -$60.5K ﹤0.01% 1808
2020
Q4 		$850K Buy
33,662
+1,480
+5% +$48.2K ﹤0.01% 1910
2020
Q3 		$1.21M Buy
32,182
+1,792
+6% +$67.6K ﹤0.01% 1584
2020
Q2 		$1.27M Buy
30,390
+3,505
+13% +$127K ﹤0.01% 1529
2020
Q1 		$523K Buy
26,885
+1,435
+6% +$34.2K ﹤0.01% 1814
2019
Q4 		$661K Sell
25,450
-976
-4% -$26.9K ﹤0.01% 1891
2019
Q3 		$720K Buy
26,426
+427
+2% +$12.2K ﹤0.01% 1812
2019
Q2 		$698K Buy
25,999
+15,875
+157% +$442K ﹤0.01% 1844
2019
Q1 		$293K Buy
+10,124
New +$294K ﹤0.01% 2278

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ALLO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Allogene Therapeutics (ALLO) stake by 35% in Q1 2026, buying an estimated $340K and bringing the position to 654,180 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Manulife (Manufacturers Life Insurance) first reported a position in ALLO in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.74M in Q2 2022. 209 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 654,180 shares of Allogene Therapeutics worth $1.6M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 169,558 Allogene Therapeutics shares in Q1 2026, an estimated $340K.
  • Allogene Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1589 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Allogene Therapeutics in Q1 2019 and has held it in 29 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Allogene Therapeutics position peaked at $1.74M in Q2 2022.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.